These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12374078)

  • 1. Combination antithrombotic therapy in acute myocardial infarction.
    Rihn TL; Vanscoy GJ
    Am J Health Syst Pharm; 2002 Oct; 59(19):1882-5. PubMed ID: 12374078
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapy for acute myocardial infarction: mechanisms and prevention of deep venous, left ventricular, and coronary artery thromboembolism.
    Chesebro JH; Fuster V
    Circulation; 1986 Nov; 74(5 Pt 2):III1-10. PubMed ID: 3533316
    [No Abstract]   [Full Text] [Related]  

  • 3. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
    Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
    Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the residual stenosis following thrombolytic therapy of acute myocardial infarction.
    Laffel G; Braunwald E
    Cardiology; 1986; 73(4-5):278-91. PubMed ID: 2944584
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antithrombotic prevention and therapy in coronary heart disease].
    Bode C; Kohler B; Moser M; Zimmermann R; Strasser RH; Kübler W
    Internist (Berl); 1997 Jul; 38(7):658-66. PubMed ID: 9333599
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging antithrombotic treatments for acute coronary syndromes.
    Golino P; Ragni M; Cirillo P; Buono C; Piro O; Chiariello M
    Cardiologia; 1999 Nov; 44(11):969-80. PubMed ID: 10686772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary thrombolysis--a perspective for the practicing physician.
    Fuster V
    N Engl J Med; 1993 Sep; 329(10):723-5. PubMed ID: 8345859
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of magnesium as antithrombotic therapy.
    Shechter M
    Wien Med Wochenschr; 2000; 150(15-16):343-7. PubMed ID: 11105330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventions.
    Widimský P; Kočka V; Roháč F; Osmančík P
    Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):131-40. PubMed ID: 27418971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy in acute myocardial infarction.
    Smucker DR; Burket MW
    Am Fam Physician; 1988 May; 37(5):265-74. PubMed ID: 3129924
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
    Reikvam A; Madsen S; Landmark K
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What an interventional cardiologist should know about the pharmacological treatment of acute myocardial infarction.
    Verheugt FW
    Semin Interv Cardiol; 1999 Mar; 4(1):17-20. PubMed ID: 10406064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombocardiology: an update.
    Arnesen H
    Expert Rev Cardiovasc Ther; 2010 Mar; 8(3):331-3. PubMed ID: 20222811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coronary insufficiency and heparin].
    Nicolau JC; Ramires JA
    Arq Bras Cardiol; 1991 Aug; 57(2):141-50. PubMed ID: 1823773
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute myocardial infarction and chronic leukaemia with significant thrombocytopenia].
    Sielski J; Wałek P; Siuda M; Polewczyk A; Kurzawski J; Janion M
    Kardiol Pol; 2011; 69(10):1072-4. PubMed ID: 22006613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V.
    Ferreira D
    Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168
    [No Abstract]   [Full Text] [Related]  

  • 19. Anistreplase for acute coronary thrombosis.
    Med Lett Drugs Ther; 1990 Feb; 32(812):15-6. PubMed ID: 2406552
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined antithrombotic therapy for acute coronary syndrome.
    Gawaz M; Müller I; Besta F
    Semin Vasc Med; 2003 May; 3(2):163-76. PubMed ID: 15199479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.